The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy DevelopmentNallasivam Palanisamy, Nora M. Navone, Jun Yang et al.|Clinical Cancer Research|2020Cited by 86
Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate CancerEstefanía Labanca, Nora M. Navone, Patricia Troncoso et al.|European Urology Oncology|2021Cited by 28
Legend of Supplementary Figures from The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy DevelopmentNallasivam Palanisamy, Nora M. Navone, Jun Yang et al.|Unknown|2023Cited by 0
Figure S5 from The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy DevelopmentNallasivam Palanisamy, Nora M. Navone, Jun Yang et al.|Unknown|2023Cited by 0
Supplementary Results from The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy DevelopmentNallasivam Palanisamy, Nora M. Navone, Jun Yang et al.|Unknown|2023Cited by 0